4D-nucleofector X unit
Ended Awarded
- Contract number
- 75N91022F00001
- Awardee
-
Lonza Walkersville, Inc. UEI LEEXJC9L4NF5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $18,944
Award facts
- Contract value 100% obligated
- $18,944.00 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a $18,944 firm fixed price BPA call to Lonza Walkersville, Inc. for a 4D-Nucleofector X Unit. The contract was awarded on September 20, 2022, with an ultimate completion date of September 19, 2023, and will be performed at the awardee's location in Bethesda, Maryland. This procurement was conducted through open competition with no set-aside designation. Lonza Walkersville is a Maryland-based subsidiary of the global Lonza Group specializing in biological research products and scientific instrumentation, including cell culture media, specialized cell lines, and transfection devices.
This contract award represents a task order against Lonza Walkersville's existing $10 million single-award BPA with the HHS Office of Logistics and Acquisition Operations, which remains valid through December 31, 2025. The 4D-Nucleofector X Unit is a specialized cell transfection device used in advanced cellular research and engineering applications. As a critical supplier to multiple NIH institutes and centers, Lonza Walkersville has consistently supported federal biomedical research initiatives through provision of sophisticated laboratory equipment and biological materials, with this delivery supporting the National Cancer Institute's research infrastructure and mission.
Quick answers
Who was awarded contract 75N91022F00001?
75N91022F00001 was awarded to Lonza Walkersville, Inc. by National Cancer Institute (National Institutes of Health) on September 20, 2022.
How much is contract 75N91022F00001 worth?
The government has obligated $18,944 on 75N91022F00001.
Is contract 75N91022F00001 an order under another contract?
Yes. 75N91022F00001 is a BPA call under HHSN263201600052B, a blanket purchase agreement.
Was contract 75N91022F00001 competed?
The extent of competition for 75N91022F00001 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award